52
Participants
Start Date
October 31, 2007
Primary Completion Date
October 31, 2009
Study Completion Date
November 30, 2009
VIA-2291
100 mg, oral dosing, 1 time daily for 24 weeks
Placebo
oral dosing, 1 time daily for 24 weeks
VIA Pharmaceuticals, San Francisco
VIA Pharmaceuticals, Princeton
Massachusetts General Hospital
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
University of Massachusetts, Worcester
OTHER
Winthrop University Hospital
OTHER
Montreal Heart Institute
OTHER
Tallikut Pharmaceuticals, Inc.
INDUSTRY